Copyright
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Oncol. Apr 24, 2022; 13(4): 303-313
Published online Apr 24, 2022. doi: 10.5306/wjco.v13.i4.303
Published online Apr 24, 2022. doi: 10.5306/wjco.v13.i4.303
Mesentery solitary fibrous tumor with postoperative recurrence and sarcomatosis: A case report and review of literature
Chong-Chi Chiu, Chao-Ming Hung, Hui-Ming Lee, Department of General Surgery, E-Da Cancer Hospital, Kaohsiung 82445, Taiwan
Chong-Chi Chiu, Chao-Ming Hung, Kun-Ming Rau, School of Medicine, College of Medicine, I-Shou University, Kaohsiung 82445, Taiwan
Chong-Chi Chiu, Department of Medical Education and Research, E-Da Cancer Hospital, Kaohsiung 82445, Taiwan
Haruaki Ishibashi, Satoshi Wakama, Yang Liu, Yutaka Yonemura, Peritoneal Surface Malignancy Center, Kishiwada Tokushukai Hospital, Osaka 596-8522, Japan
Yuan Hao, Department of General Surgery, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
Po-Huang Lee, Department of General Surgery, E-Da Hospital, Kaohsiung 82445, Taiwan
Po-Huang Lee, Hui-Ming Lee, College of Medicine, I-Shou University, Kaohsiung 82445, Taiwan
Kun-Ming Rau, Department of Hematology & Oncology, E-Da Cancer Hospital, Kaohsiung 82445, Taiwan
Author contributions: Chiu CC collected clinical records, wrote, revised and submitted the draft; Ishibashi H, Wakama S and Liu Y assisted with the operation and cared for the patient; Hao Y and Liu Y assisted with photo management; Hung CM provided critical opinion; Lee PH revised the manuscript; Rau KM and Lee HM searched the related references during the preparation process; Yonemura Y performed the operation, provided critical feedback, supervision, and opinion of this study.
Informed consent statement: Written informed consent for the publication of this case report was obtained from the patient.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Yutaka Yonemura, PhD, Professor, Peritoneal Surface Malignancy Center, Kishiwada Tokushukai Hospital, 4-27-1 Kamori-Cho, Kishiwada, Osaka 596-8522, Japan. y.yonemura@coda.ocn.ne.jp
Received: November 25, 2021
Peer-review started: November 25, 2021
First decision: January 12, 2022
Revised: January 20, 2022
Accepted: March 27, 2022
Article in press: March 27, 2022
Published online: April 24, 2022
Processing time: 148 Days and 0.1 Hours
Peer-review started: November 25, 2021
First decision: January 12, 2022
Revised: January 20, 2022
Accepted: March 27, 2022
Article in press: March 27, 2022
Published online: April 24, 2022
Processing time: 148 Days and 0.1 Hours
Core Tip
Core Tip: Solitary fibrous tumors (SFTs) are mostly benign and they rarely develop in the mesentery and cause sarcomatosis. The favored treatment strategy is whole-tumor excision with continued follow-up. According to a literature review, our patient is the first case report of mesentery SFT with the presentation of postoperative intraperitoneal recurrence and sarcomatosis.